Skip to main content
. 2016 Jan 22;95(3):e2524. doi: 10.1097/MD.0000000000002524

FIGURE 7.

FIGURE 7

Case 3: A 45-year-old man presented with a 12-month history of central serous chorioretinopathy (CSC) in the left eye. His left best-correct visual acuity (BCVA) was 20/50. He had been treated with intravitreal injection of bevacizumab about 4 months previously. Selective retina therapy (SRT) was applied to the area of focal juxtafoveal angiographic leakages. His persistent subretinal fluid (SRF) completely resolved within 1 month. The BCVA remained unchanged. (A) Two leaking points on fundus fluorescein angiography (FFA) and SRF on optical coherence tomography (OCT) were observed at initial presentation. (B) Two SRT laser spots near 2 leaking points (yellow arrow) and 3 test spots (red arrow) were shown on FFA 30 minutes after SRT treatment. (C) Fundus autofluorescence (FAF) showed hyperautofluorescence at test spots at 1 month. (D) Hyperautofluorescence at test spots nearly disappeared at 3 months. (E) No scar was seen at SRT-treated sites. Complete resolution of SRF was shown on OCT 3 months after SRT. (F) Microperimetry (MP) showed no scotoma at 4 months after SRT.